As a result, KKR will become the largest non-index fund shareholder in the Company with a 12% position, demonstrating the firm’s confidence in Henry Schein, its management team, and its BOLD+1 ...

Charles R. Goulding and Preeti Sulibhavi explain how KKR’s investment in Henry Schein signals a transformative shift in ...

Q4 2024 Management View CEO Stanley Bergman highlighted the completion of the 2022-2024 BOLD+1 Strategic Plan, exceeding the target of generating 40% of worldwide operating income from high-growth, ...

Henry Schein (NASDAQ:HSIC) announced Wednesday a strategic investment from funds affiliated with private equity firm KKR (NYSE:KKR) and released its preliminary Q4 2024 financials and full-year ...

Henry Schein (HSIC) announced a strategic investment by funds affiliated with KKR,(KKR) a global investment firm.In addition to KKR’s current holdings, KKR will make an additional $250M ...

Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation. Shares of the company fell ...

KKR to invest $250M in Henry Schein, increasing stake to 12%, with an option to reach 14.9%. Henry Schein raises share buyback program by $500M and expects moderate revenue and EPS growth in 2025.

Jan 29 (Reuters) - Private equity firm KKR (KKR.N), opens new tab has taken a large stake in Henry Schein (HSIC.O), opens new tab and reached a deal to add members to the company's board ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...

Henry Schein and KKR will collaborate on a range of value-creation opportunities. Henry Schein will issue new shares of common stock to funds affiliated with KKR for a $250 million investment ...